Asymchem, a leading global contract development and manufacturing organization (CDMO), announced that its dedicated carbapenem API manufacturing facility (Jilin Asymchem Pharmaceuticals Co. Ltd., also ...

Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...

According to the latest market analysis by Future Market Insights, the global Acetonitrile Market is projected to grow from USD 325.2 million in 2025 to USD 567.5 million by 2035, registering a CAGR ...

Garonit Pharmaceutical, an India-based API maker, plans to build a $46.1 million production plant in New York to produce chlorhexidine gluconate, which is primarily used as an antiseptic and surgical ...

India, July 21 -- Under the Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active ...

Eli Lilly’s breast cancer med Verzenio may look like your standard drug tablet—ovular, off-white, emblazoned with the dosage on the front and Lilly’s logo on the reverse—but behind that modest façade ...

India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

Even as the Trump administration has threatened imposing tariffs of up to 200% on generic pharmaceutical exports to the US ...

According to the latest market analysis by Future Market Insights, the global Recycled Pharma Solvents Market is entering a new phase of sustainable ...